Prostate Cancer
Clinical Trials

1) First Line Metastatic mCRPC: USO #19191: BMS CA209-7DX: A Phase 3 Randomized, Double-Blind Study of Nivolumab or Placebo in Combination with Docetaxel, in Men with Metastatic Castration-resistant Prostate Cancer (Check-Mate 7DX: CHECKpoint pathway and nivoluMAB clinical Trial Evaluation 7DX)

2) Cohort 21 and 23 part of XL184-021 EXELIXIS: A Phase Ib Dose-Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination with Atezolizumab to Subjects with Locally Advanced or Metastatic Solid Tumors (More information under Prostate Cancer/Solid Tumors Section)

Send UsA Message

    A Grateful Patient’s Breast Cancer Journey

    A Grateful Patient’s Breast Cancer Journey

    I am currently undergoing treatment for breast cancer at Roper St. Francis Hospital and would like to acknowledge two physicians who truly embody your mission of “healing with compassion, faith and excellence”.

    read more
    National Cancer Survivor Month

    National Cancer Survivor Month

    Please join Charleston Oncology and the American Association for Cancer Research (AACR) in support of National Survivor Month, celebrating those who have fought the disease and those currently in treatment.

    read more
    Call Now Button